LION:NYSELionsgate Studios Corp Analysis
Data as of 2026-04-15 - not real-time
$11.09
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Lionsgate Studios Corp. is displaying a strong bullish technical profile. The 20‑day moving average sits comfortably above the 50‑day average, while the MACD line remains above its signal, indicating upward momentum. Momentum is further underscored by an RSI that has entered overbought territory, suggesting recent price acceleration. Trading volume has been on an upswing, supporting the price rally toward the identified resistance zone. Market sentiment is at an extreme greed level, reflecting heightened investor optimism.
On the valuation side, the stock trades at a lofty forward price‑to‑earnings multiple and a negative price‑to‑book ratio, flagging potential overvaluation given the absence of reported earnings or cash flow. No dividend is being paid, eliminating income‑focused appeal. Growth arguments stem from a sizable IP library and a recent partnership that could unlock new revenue streams, but these are largely speculative without concrete financial data. Analyst coverage is mixed, with a consensus “buy” recommendation but a recent “hold” from another firm. Risk considerations include elevated 30‑day volatility and a modest beta, indicating price swings that may outpace market moves. Liquidity appears adequate, with volume trending higher than average, but the high valuation and volatility elevate overall risk.
On the valuation side, the stock trades at a lofty forward price‑to‑earnings multiple and a negative price‑to‑book ratio, flagging potential overvaluation given the absence of reported earnings or cash flow. No dividend is being paid, eliminating income‑focused appeal. Growth arguments stem from a sizable IP library and a recent partnership that could unlock new revenue streams, but these are largely speculative without concrete financial data. Analyst coverage is mixed, with a consensus “buy” recommendation but a recent “hold” from another firm. Risk considerations include elevated 30‑day volatility and a modest beta, indicating price swings that may outpace market moves. Liquidity appears adequate, with volume trending higher than average, but the high valuation and volatility elevate overall risk.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Bullish technical alignment but RSI overbought
- Price approaching resistance with limited upside
- High market greed may fuel short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strategic partnership could unlock new revenue streams
- Strong IP library provides growth runway
- Increasing volume supports sustained interest
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Elevated valuation metrics without solid earnings foundation
- Persistent high volatility may erode returns
- Lack of dividend limits total return potential
Key Metrics & Analysis
Financial Health
P/E Ratio53.8
P/B Ratio-2.5
Technical Analysis
TrendBullish
RSI72.4
Support$9.11
Resistance$11.40
MA 20$9.86
MA 50$9.41
MA 200$7.67
MACDBullish
VolumeIncreasing
Fear & Greed Index88.64
Valuation
Target Price$11.28
Upside/Downside1.69%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta0.68
Volatility46.43%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.